CalciMedica, Inc. (CALC) stock
CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.22+0.03 (+2.52%)
Close on Nov 17, 2026Market cap $41.65MP/E –Yield –
CalciMedica total assets
Total assets on the balance sheet at the end of each period.
CalciMedica's total assets was $19.50M at Jun 30, 2026. For fiscal 2025 it was $13.59M, down 31.3% from the year before. The highest annual figure on record is $101.79M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.59M | -31.3% |
| FY2024 | Dec 31, 2024 | $19.79M | +62.4% |
| FY2023 | Dec 31, 2023 | $12.19M | +263.8% |
| FY2022 | Dec 31, 2022 | $3.35M | -95.2% |
| FY2021 | Dec 31, 2021 | $69.09M | -32.1% |
| FY2020 | Dec 31, 2020 | $101.79M | +150.4% |
| FY2019 | Dec 31, 2019 | $40.66M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.50M | +2.2% |
| Q1 FY2026 | Mar 31, 2026 | $8.61M | -66.0% |
| Q4 FY2025 | Dec 31, 2025 | $13.59M | -31.3% |
| Q3 FY2025 | Sep 30, 2025 | $14.91M | -8.0% |
| Q2 FY2025 | Jun 30, 2025 | $19.08M | -9.4% |
| Q1 FY2025 | Mar 31, 2025 | $25.35M | -6.6% |
| Q4 FY2024 | Dec 31, 2024 | $19.79M | +62.4% |
| Q3 FY2024 | Sep 30, 2024 | $16.21M | +2.3% |
| Q2 FY2024 | Jun 30, 2024 | $21.05M | +4.0% |
| Q1 FY2024 | Mar 31, 2024 | $27.13M | -21.7% |
| Q4 FY2023 | Dec 31, 2023 | $12.19M | +263.8% |
| Q3 FY2023 | Sep 30, 2023 | $15.85M | -70.7% |
| Q2 FY2023 | Jun 30, 2023 | $20.25M | -66.6% |
| Q1 FY2023 | Mar 31, 2023 | $34.67M | -49.8% |
| Q4 FY2022 | Dec 31, 2022 | $3.35M | -95.6% |
| Q2 FY2022 | Jun 30, 2022 | $54.02M | -34.8% |
| Q1 FY2022 | Mar 31, 2022 | $60.59M | -33.3% |
| Q4 FY2021 | Dec 31, 2021 | $69.09M | -32.1% |
| Q3 FY2021 | Sep 30, 2021 | $76.64M | -22.1% |
| Q2 FY2021 | Jun 30, 2021 | $82.82M | +103.7% |
| Q1 FY2021 | Mar 31, 2021 | $90.85M | – |
| Q4 FY2020 | Dec 31, 2020 | $101.79M | – |
| Q3 FY2020 | Sep 30, 2020 | $98.39M | – |
| Q4 FY2019 | Dec 31, 2019 | $40.66M | – |
See a number that looks wrong?